Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation.

about

Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients Inappropriate inferences from registry data: Pitfalls of inaccurate data handling?

P2860

Q26766049-3BB68B4F-8B07-4F5F-BB5D-011B54D71DD7 Q44073825-B58D7B23-583D-4D80-B51E-3025F1C57A62

P2860

Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation.

Item

http://www.wikidata.org/entity/Q54544776

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Antiviral therapy for recurren ...... llowing liver transplantation.

@en

Antiviral therapy for recurren ...... llowing liver transplantation.

@nl

type

Item

label

Antiviral therapy for recurren ...... llowing liver transplantation.

@en

Antiviral therapy for recurren ...... llowing liver transplantation.

@nl

prefLabel

Antiviral therapy for recurren ...... llowing liver transplantation.

@en

Antiviral therapy for recurren ...... llowing liver transplantation.

@nl

P1476

Antiviral therapy for recurren ...... llowing liver transplantation.

@en

P2093

Ashish Singhal

http://www.w3.org/2001/XMLSchema#string

Lenzi Elliott

http://www.w3.org/2001/XMLSchema#string

Sajid Jalil

http://www.w3.org/2001/XMLSchema#string

Vivek Kohli

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

Management of hepatocellular carcinoma

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial.

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

Viral hepatocarcinogenesis.

P304

192-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1432-2277.2011.01396.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51861762

http://www.w3.org/2001/XMLSchema#string

P698

22151471

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation.

about

P2860

P2860

Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921